Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
UCB SA (EBR: UCB) bets $1.15 bn on Neurona Therapeutics to push epilepsy treatment beyond symptom control
Read More Healthcare Industry News DEKA unveils PelviTouch therapy as non-invasive solution for erectile dysfunction at ESSM Congress DEKA Laser, a subsidiary of El.En. S.p.A., has introduced PelviTouch therapy, a groundbreaking non-invasive treatment for erectile dysfunction… byPallavi MadhirajuFebruary 23, 2025